Moleculin Biotech is trading 5% lower at $0.48, with no clear company-specific explanation identified for the October 2 move. - Its latest listed releases were dated September 29 and September 28; neither establishes a cause for the decline. - Supplied broader-market indices are higher, and available evidence does not show the stock moving with the market.